Sarcosine1,glycine8 angiotensin II is an AT 1 angiotensin II receptor subtype selective antagonist

Regulatory Peptides

Volumn 115, Issue 3, 2003, Pages 203-209

  Speth, Robert C ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Adrenal; Brain; Liver; Pituitary; Radioligand binding

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN RECEPTOR; GLYCINE; IODINE 125; ISOLEUCINE; SARCOSINE; ANGIOTENSIN RECEPTOR ANTAGONIST; SARCOSINE(1) ANGIOTENSIN II RECEPTOR; SARCOSINE(1)-ANGIOTENSIN II RECEPTOR;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; DRUG ANTAGONISM; HYPOPHYSIS; HYPOTHALAMUS; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THIRST; AMINO ACID SEQUENCE; ANIMAL; BINDING COMPETITION; CHEMISTRY; COMPARATIVE STUDY; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SPRAGUE DAWLEY RAT;

BOVINAE;

ADRENAL GLANDS; AMINO ACID SEQUENCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; GLYCINE; LIVER; MALE; MOLECULAR SEQUENCE DATA; PITUITARY GLAND; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN;

EID: 0141861934     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00172-1     Document Type: Article

References (46)

1. Fitzsimons J.T. The physiology of thirst and sodium appetite. 1979;Cambridge Univ. Press, Cambridge.
2. Bennett J.P. Jr., Snyder S.H. Angiotensin II binding to mammalian brain membranes. J. Biol. Chem. 251:1976;7423-7430.
3. Regoli D., Rioux F., Park W.K., Choi C. Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues. Can. J. Physiol. Pharmacol. 52:1974;39-49.
4. Whitebread S., Mele M., Kamber B., de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163:1989;284-291.
5. Chiu A.T., Herblin W.F., McCall D.E., Ardecky R.J., Carini D.J., Duncia J.V.et al. Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 165:1989;196-203.
6. Beresford M.J., Fitzsimons J.T. Intracerebroventricular angiotensin II-induced thirst and sodium appetite in rat are blocked by the AT1 receptor antagonist, Losartan (DuP 753), but not by the AT2 antagonist, CGP 42112B. Exp. Physiol. 77:1992;761-764.
7. Smith R.D., Chiu A.T., Wong P.C., Herblin W.F., Timmermans P.B.M.W.M. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32:1992;135-165.
8. Bottari S.P., Taylor V., King I.N., Bogdal Y., Whitebread S., de Gasparo M. Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins. Eur. J. Pharmacol. 207:1991;157-163.
9. Tian Y., Baukal A.J., Sandberg K., Bernstein K.E., Balla T., Catt K.J. Properties of AT(1a) and AT(1b) angiotensin receptors expressed in adrenocortical Y-1 cells. Am. J. Physiol.: Endocrinol. Metab. 33:1996;E831-E839.
10. 3H]losartan in the rat liver. Biochem. Pharmacol. 46:1993;1653-1660.
11. 1 angiotensin receptor. Biochem. Biophys. Res. Commun. 188:1992;1030-1039.
12. 3H] SK&F 108566 as a radioligand for angiotensin type-1 receptor. J. Recept. Res. 13(5):1993;849-861.
13. Llorens-Cortes C., Greenberg B., Huang H., Corvol P. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension. 24:1994;538-548.
14. Lenkei Z., Palkovits M., Corvol P., Llorenscortes C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front. Neuroendocrinol. 18:1997;383-439.
15. Healy D.P., Ye M.Q., Troyanovskaya M. Localization of angiotensin II type 1 receptor subtype mRNA in rat kidney. Am. J. Physiol. 268:1995;F220-F226.
16. Gasc J.M., Shanmugam S., Sibony M., Corvol P. Tissue-specific expression of type 1 angiotensin II receptor subtypes - an in situ hybridization study. Hypertension. 24:1994;531-537.
17. 6 angiotensin II. Biochem. Biophys. Res. Commun. 169:1990;997-1006.
18. Rowe B.P., Grove K.L., Saylor D.L., Speth R.C. Angiotensin II receptor subtypes in the rat brain. Eur. J. Pharmacol. 186:1990;339-342.
19. Kakar S.S., Sellers J.C., Devor D.C., Musgrove L.C., Neill J.D. Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem. Biophys. Res. Commun. 183:1992;1090-1096.
20. Seltzer A., Pinto J.E.B., Viglione P.N., Correa F.M.A., Libertun C., Tsutsumi K.et al. Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology. 55:1992;460-467.
21. Qiu J., Nelson S.H., Speth R.C., Wang D.H. Regulation of adrenal angiotensin receptor subtypes: a possible mechanism for sympathectomy-induced adrenal hypertrophy. J. Hypertens. 17:1999;933-940.
22. Speth R.C., Grove K.L., Brownfield M.S. Immunohistochemical localization of AT-1A and AT-1B angiotensin II receptor subtypes in the rat adrenal. Endocrin. Soc. Abstr. 83:2001;P3-P180.
23. Lu X.-Y., Grove K.L., Zhang W., Speth R.C. Pharmacological characterization of angiotensin II AT2 receptor subtype heterogeneity in the rat adrenal cortex and medulla. Endocrine. 3:1995;255-261.
24. Speth R.C., Harding J.W. Radiolabeling of angiotensin peptides. Wang D.H. Angiotensin protocols. 2001;275-295 Humana Press, Totowa, NJ.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. Murphy T.J., Alexander R.W., Griendling K.K., Runge M.S., Bernstein K.E. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 351:1991;233-236.
27. Kambayashi Y., Bardhan S., Takahashi K., Tsuzuki S., Inui H., Hamakubo T.et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268:1993;24543-24546.
28. Mukoyama M., Nakajima M., Horiuchi M., Sasamura H., Pratt R.E., Dzau V.J. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 268:1993;24539-24542.
29. Noda K., Saad Y., Kinoshita A., Boyle T.P., Graham R.M., Husain A.et al. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. JBC. 270:1995;2284-2289.
30. Feng Y.H., Noda K., Saad Y., Liu X.P., Husain A., Karnik S.S. The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism. J. Biol. Chem. 270:1995;12846-12850.
31. Noda K., Saad Y., Karnik S.S. Interaction of Phe(8) of angiotensin II with Lys(199) and His(256) of AT(1) receptor in agonist activation. J. Biol. Chem. 270:1995;28511-28514.
32. Joseph M.P., Maigret B., Bonnafous J.C., Marie J., Scheraga H.A. A computer modeling postulated mechanism for angiotensin II receptor activation. J. Protein Chem. 14:1995;381-398.
33. Holloway A.C., Qian H., Pipolo L., Ziogas J., Miura S., Karnik S.et al. Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol. Pharmacol. 61:2002;768-777.
34. Knowle D., Kurfis J., Gavini N., Pulakat L. Role of Asp297 of the AT2 receptor in high-affinity binding to different peptide ligands. Peptides. 22:2001;2145-2149.
35. Yee D.K., Kisley L.R., Heerding J.N., Fluharty S.J. Mutation of a conserved fifth transmembrane domain lysine residue (Lys215) attenuates ligand binding in the angiotensin II type 2 receptor. Brain Res., Mol. Brain Res. 51:1997;238-241.
36. Pulakat L., Tadessee A.S., Dittus J.J., Gavini N. Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction. Regul. Pept. 73:1998;51-57.
37. Khairallah P.A., Toth A., Bumpus F.M. Analogs of angiotensin II. Mechanism of receptor interaction. J. Med. Chem. 13:1970;181.
38. Marshall G.R., Vine W., Needleman P. A specific competitive inhibitor of angiotensin II. Proc. Natl. Acad. Sci. U. S. A. 67:1970;1624.
39. Regoli D., Park W.K., Rioux F. Pharmacology of angiotensin. Pharmacol. Rev. 26:1974;69-123.
40. Yamano Y., Ohyama K., Kikyo M., Sano T., Nakagomi Y., Inoue Y.et al. Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT1). J. Biol. Chem. 270:1995;14024-14030.
41. Turner C.A., Cooper S., Pulakat L. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. Biochem. Biophys. Res. Commun. 257:1999;704-707.
42. Brechler V., Reichlin S., de Gasparo M., Bottari S.P. Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Recept. Channels. 2:1994;89-98.
43. Whitebread S.E., Taylor V., Bottari S.P., Kamber B., de Gasparo M. Radioiodinated CGP 42112A: a novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptors. Biochem. Biophys. Res. Commun. 181:1991;1365-1371.
44. 125I-glucagon. J. Biol. Chem. 246:1971;1872-1876.
45. Crane J.K., Campanile C.P., Garrison J.C. The hepatic angiotensin II receptor II. Effect of guanine nucleotides and interaction with cyclic AMP production. J. Biol. Chem. 257:1982;4959-4965.
46. Schmid C., Castrop H., Reitbauer J., Dellabruna R., Kurtz A. Dietary salt intake modulates angiotensin II type 1 receptor gene expression. Hypertension. 29(4):1997;923-929.